NCADD national said: "We are grateful for your affiliation with us and proud of the excellent services you provide to your community. We are highlighting you on our Facebook Page, Affiliate of the Month<https://www.facebook.com/notes/national-council-on-alcoholism-and-drug-dependence-ncadd-national-office/ncadd-sd-san-diego-ca-affiliate-of-the-month-march-2018/1744890972237190/>, and on the NCADD website, Affiliate of the Month<https://www.ncadd.org/blogs/affiliate-of-the-month/ncadd-sd-san-diego-ca-affiliate-of-the-month-march-2018>, to share your good work with the public and to demonstrate our pride and appreciation of your agency's work."
We are completely humbled by the honor.
More than 500,000 people have died from prescription drug overdoses just since the year 2000 – while the industry making these opioids earned an estimated $200 billion from the sales of these pills. Beyond this staggering human toll, prescription opioid misuse costs our economy nearly $80 billion per year. Today, more than three-quarters of those suffering from heroin addiction used prescription opioids prior to heroin.
How we got to this point is complicated. But one thing is clear: the crisis began with big pharma’s great Opioid Lie.
The Addiction Policy Forum is coordinating a response to the President's Commission Recommendations on Combatting Drug Addiction and the Opioid Crisis. You can read the final report here.
You can help the Addiction Policy Forum by completing their survey by clicking the button below and giving your views.
Last week, the House of Representatives passed S. 524, the Comprehensive Addiction and Recovery Act of 2016 by a vote of 407-5. The bill is now headed to the Senate and then to President Obama for his signature. It has been almost three years since the bill was first introduced.
CARA would expand prevention and education initiatives, strengthen prescription drug monitoring programs, expand availability of naloxone and provide necessary training to expand treatment for opioid and heroin addiction.
For details on the bill, click here.
The Department of Health and Human Services (DHHS) issued final regulations intended to increase access to medication-assisted treatment with buprenorphine products in physician offices. The new limit, effective August 5, 2016 when the regulation goes into effect, will be 275 patients. There are several eligibility requirements for physicians including having a current waiver to treat up to 100 patients and maintaining that waiver for at least one year. Other requirements include being Board-certified in addiction medicine or addiction psychiatry; practicing in a qualified practice; having no Medicare privilege revocations, and no violations of the Controlled Substances Act. For full details, click here.
Ask Your Senator or Representative to Support the Comprehensive Addiction and Recovery Act (CARA) of 2015 | Faces & Voices of Recovery.
On October 4, 2015 NCADD-SD will be supporting Facing Addiction, along with more than 600 organizations from around the world, will gather in a show of solidarity to UNITE to Face Addiction and end the silence around our most urgent health crisis. Together we can help the 22 million Americans with addiction, stand up for the 23 million more in recovery, and urgently act to save the 350 lives lost each day.
Jane Giatras and I had the good fortune of spending a week at the NCADA affiliate in St Louis Missouri. The Midwest hospitality was awesome.
NCADA (National Council on Alcoholism and Drug Abuse) has been in existence for 50 years and began very much like the NCADD-SD is planning. With one school, one program, and one trainer. Their program has now grown to include 50 trainers managing a wide array of drug and alcohol prevention training.
By accepting you will be accessing a service provided by a third-party external to https://www.ncadd-sd.org/
© 2021 NCADD San Diego All Rights Reserved
mhpmm.com created and supported website